DR. HULSHER: "ALCUNI LOTTI DI VACCINI PFIZER ERANO MOLTO PIÙ PERICOLOSI"❗ Erano contrassegnati dalla lettera "E" ("Excess"). Furono distribuiti tra dicembre '20 e aprile '21. Sono i responsabili di quasi tutti i decessi e gli effetti avversi gravi! 🫣 DR. HULSHER: "SOME PFIZER VACCINES BATCHES WERE MUCH MORE DANGEROUS"❗ They were marked with the letter "E" ("Excess"). They were distributed between December '20 and April '21. They are responsible for almost all the deaths and serious adverse effects! 🫣 https://x.com/M25016096/status/1920915281238782157?t=urJ2yz81c_5bhOUcZnQ0Qw&s=19

Dr. William Makis MD: Ho dedicato 2 anni a scrivere di Turbo Cancro, I vaccini mRNA contro il COVID-19 di Pfizer e Moderna causano i cosiddetti "tumori turbo". I primi 5 sono: 1. Linfomi 2. Tumori cerebrali 3. Tumori al seno 4. Colon 5. Polmone Source: https://x.com/Adriano72197026/status/1918757434652229887?t=r-RGq67AIGopZc0Ntm4LeA&s=19

Per chi non avesse ancora capito, questa mossa del governo Trump in pratica elimina la possibilità di nuovi vaccini. Quasi nessuno dei vaccini esistenti potrebbe passare test clinici dimostrando sicurezza ed efficacia contro un placebo. È un atto talmente rivoluzionario che stento ancora a crederci. E mi domando come potranno venire approvati nel resto del mondo dei "vaccini" non approvati negli USA. For those who haven't figured it out yet, this move by the Trump administration essentially eliminates the possibility of new vaccines. Almost none of the existing vaccines could pass clinical trials demonstrating safety and efficacy against a placebo. This is such a revolutionary act that I still can't believe it. And I wonder how "vaccines" not approved in the US could be approved in the rest of the world. Source: https://x.com/MarcoDabizzi/status/1918177376753860627?t=96j7WrR4qYtLAdwCs18B4A&s=19

🇪🇺 C'È UN PIANO DELLA UE PER AFFOSSARE L'INDUSTRIA AUTOMOBILISTICA❓ Sfogo del rivenditore Maserati: "Non ho le prove, ma ne sono assolutamente certo: la burocrazia UE, forse collusa ed infiltrata da interessi stranieri, con la scusa del Clima sta deliberatamente affossando la nostra industria dell'auto. Prima con le norme sulle emissioni, che hanno mandato fuori mercato i diesel e così svalutato investimenti in ricerca e brevetti per miliardi, poi mettendo fuori legge tutte le auto a motore termico. Tutti sappiamo che dovranno rimangiarsi il divieto, ma intanto ci hanno reso impossibile fare piani industriali sostenibili. Risultato: tutta le case europee, con perdite pazzesche, chiudono stabilimenti, licenziano e vendono marchi. Guardi a quanti operai dava lavoro la FIAT nel 1980 e a quanti oggi " Gli ho domandato: "Chi sarebbe questa potenza straniera che tirerebbe i fili?". Lui mi ha risposto: "Guardi di che nazionalità sono le uniche marche che vanno bene, che fanno acquisizioni in Europa, e quasi certamente rileveranno anche la Maserati ..." 🫣 THERE IS AN EU PLAN TO SINK THE AUTOMOTIVE INDUSTRY❓ A Maserati dealer vents: "I don't have proof, but I'm absolutely certain: the EU bureaucracy, perhaps colluded and infiltrated by foreign interests, is deliberately sinking our auto industry under the guise of Climate. First with emissions regulations, which have pushed diesels out of the market and thus devalued billions of investments in research and patents, then by outlawing all internal combustion engine cars. We all know that they will have to eat their words on the ban, but in the meantime they have made it impossible for us to make sustainable industrial plans. Result: all European companies, with crazy losses, are closing factories, laying off workers and selling brands. Look at how many workers FIAT employed in 1980 and how many today " I asked him: "Who would this foreign power be that would pull the strings?". He replied to me: "Look at what nationality they are, the only brands that are doing well, that are making acquisitions in Europe, and they will almost certainly also take over Maserati ..." 🫣

The global cheese powder market is experiencing significant growth, driven by the increasing demand for convenient food options, flavor innovations, and the rising popularity of Western cuisines in emerging markets. The global Cheese Powder market size is expected to reach USD 9.90 billion by 2032, according to a new study by Polaris Market Research. Market Overview Cheese powder, known for its extended shelf life, ease of storage, and versatile applications, has become a staple ingredient in various food products, including snacks, sauces, dressings, and ready-to-eat meals. The convenience and rich flavor profile of cheese powder make it an attractive option for both manufacturers and consumers seeking quick meal solutions without compromising on taste. Key Market Growth Drivers Rising Demand for Ready-to-Eat and Convenience Foods: The fast-paced lifestyles of consumers have led to an increased preference for ready-to-eat (RTE) and ready-to-cook (RTC) meals. Cheese powder serves as a convenient flavoring agent in these products, enhancing taste while simplifying preparation . Flavor Innovations and Product Diversification: Manufacturers are investing in research and development to introduce diverse cheese powder flavors, such as aged cheddar, blue cheese, gouda, and smoked varieties, catering to evolving consumer tastes and preferences . Health-Conscious Offerings: The growing consumer preference for healthier food options has led to the development of organic, clean-label, and nutrient-fortified cheese powders. These products align with the demand for natural ingredients free from artificial additives and preservatives . Expansion in Emerging Markets: The increasing popularity of Western cuisines in regions like Asia-Pacific is driving the demand for cheese powder-infused products. Urbanization, rising disposable incomes, and changing dietary habits contribute to this trend . Market Challenges Despite the positive outlook, the cheese powder market faces several challenges: Health Concerns: High sodium and fat content in cheese powder may deter health-conscious consumers, impacting market growth. Additionally, potential contaminants like phthalates raise safety concerns . Fluctuating Raw Material Prices: Variations in cheese prices can affect production costs and profit margins for manufacturers, posing a challenge to market stability . Regulatory Compliance: Navigating diverse food safety regulations across regions requires manufacturers to adapt their processes and formulations, which can be resource-intensive . 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/cheese-powder-market Regional Analysis North America: Holding a significant share of the global market, North America's dominance is attributed to high consumption of processed foods and snacks. The region's inclination towards convenience foods and RTE meals further propels market growth . Europe: Europe remains a key market, with countries like Germany and the Netherlands exhibiting a refined appreciation for premium cheese flavors. The demand for authentic and natural ingredients drives the adoption of cheese powder in various culinary applications . Asia-Pacific: Expected to be the fastest-growing region, Asia-Pacific's market expansion is fueled by urbanization, increased disposable incomes, and the Westernization of diets in countries such as China, India, Japan, and Australia . Key Companies Several prominent players are shaping the cheese powder market through strategic initiatives: Kerry Group PLC: Strengthened its market position by acquiring The Kraft Heinz Company's powdered cheese business, expanding its scale and manufacturing capabilities . Land O'Lakes, Inc.: Collaborated with Fonterra Co-operative Group to enhance its foodservice offerings in the U.S., aiming to tap into new channels and markets . Lactosan A/S: Introduced innovative products like the 4-cheeses powder, combining mozzarella, cheddar, blue cheese, and extra hard cheese to offer a rich-tasting cheese powder . Butter Buds Inc.: Launched Cheese Buds Simple Cheddar Cheese Concentrate, a clean-label solution delivering authentic cheddar flavor, catering to the demand for natural ingredients . Conclusion The global cheese powder market is poised for substantial growth, driven by consumer demand for convenience, flavor diversity, and healthier food options. While challenges like health concerns and regulatory compliance persist, ongoing innovations and strategic partnerships among key players are expected to navigate these hurdles, ensuring sustained market expansion in the coming years. More Trending Latest Reports By Polaris Market Research: Data Center Market Chronic Obstructive Pulmonary Disease Market Cable Modem Termination System (CMTS) and Converged Cabel Access Platform (CCAP) Market Satellite Internet Market Corn Market Digital Printing Market Food Grade Gases Market Automotive Brake System Market 3D Ultrasound Market

*📍terapia semplice poco costosa e salvavita* 📌 Da diffondere e far girare. *Da parte del Dottor Carlo Bruni,*. "Il Silenzio degli Innocenti. Muore in silenzio bambina a Cremona. Un'altra bambina va a scuola e non si accorge che la manma gli è morta accanto in silenzio. Calciatore mentre corre si accascia a terra come folgorato,.anche lui muore senza un gemito. È un continuo... Perché questi ragazzi nonostante il defribillatore muoiono? Semplice si attiva una DIC o Cid ed è finita. Cos’è’ una CID? Coagulazione Intravasale Disseminata. Nella clip che ho messo potete vedere il fenomeno della Cid in una flebo di un anziano. Immaginatevi se questo fenomeno avviene nel nostro corpo? Il meccanismo di attivazione è ovviamente Spike mediato. Aumento di Citochine infiammatorie, aumento radicali liberi, stress ossidativo alle stelle, poca stabilità elettrica fra globuli rossi che si attraggono, aumentano fibrina e fibrinogeno e succede quello che vedete. Il cuore non c’entra nulla. Sono tutte persone sanissime Che come fulminati si accasciano tutti in silenzio. Ho fatto anni di Pronto Soccorso e di infarti ne ho visti tanti e ne abbiamo salvati parecchi. La persona con un problema cardiaco viene avvisata da *progressivi dolori al petto.Sudorazione fredda, pallore insomma il corpo ti dà segnali precisi e il tempo per intervenire* . *La Coagulazione Intravasale Disseminata è fulminante.* *Avete mai visto una persona venire in PS x un infarto vero❓.* Certi urlano, tremano dai dolori. *Queste invece sono morti silenziose.* Il *rimedio* c’è eccome: **Rendere più Fluido il Sangue* Con dei *semplici rimedi* : La *Vitamina D, dosata almeno a 70, ha una spiccata attività antitrombotica,** così come gli *Omega 3 presi tutti i giorni hanno una duplice azione Anticoagulante e Antiaritmica.* Uno *studio tutto italiano* sul post infarto certifica che *chi prendeva regolarmente gli omega 3 aveva 40% di morte cardiaca improvvisa in meno.* Se poi vogliamo chiudere il cerchio diamo a tutti questi ragazzi *NAC (Natural Acetilcisteina) e Bromelina che degradano eventuale proteina spike* che si forma. *Dosaggio di Nac e Bromelina 600 mg al giorno a digiuno.* C’è un considerevole numero di vaccinati che a causa dell’integrazione dell’MRNA nel genoma ha costantemente *valori di Spike alti.* Studio pubblicato da Science Dirrecy Come si può sapere❓ Basta fare il *dosaggio ematico degli anticorpi anti Sars Cov 2.* In diversi pazienti li ho trovati alti a distanza di anni dalla vaccinazione. *Ho in terapia più di 1500 vaccinati stanno meglio di me.* Zero morti improvvise Zero neoplasie Sistema immunitario forte. Zero polmoniti o altro *Ditelo ai ragazzi, ai genitori, agli amici.* Facciamo girare questa *terapia semplice poco costosa e salvavita* . Basta Angeli che Volano via. E’ una terapia che ha studi scientifici di efficacia e sicurezza alle spalle. Io stesso la faccio da 20 anni su suggerimento del mio cardiologo. Ho il colesterolo alto a 320 dalla nascita e sono allergico a tutto. Come al solito non si dorme, ma si pensa a salvare vite umane…. Un abbraccio di Luce e Speranza a tutti. Una cortesia fate girare, magari col vostro aiuto salviamo qualche vita. P.S. l’abbinata Vitamina D e Omega 3 inoltre rimodula e rinforza il sistema immunitario. La somministravano un tempo ai bambini attraverso un bel cucchiaio di olio di fegato di merluzzo."

The global Respiratory Care Devices Market is poised for significant expansion over the coming decade, driven by rising prevalence of chronic respiratory diseases, technological advancements in respiratory monitoring, and a growing geriatric population. As respiratory conditions like COPD (Chronic Obstructive Pulmonary Disease), asthma, and sleep apnea become more widespread, the demand for both in-hospital and home respiratory monitoring solutions is set to escalate. The global respiratory care devices market size is expected to reach USD 44.96 billion by 2032, according to a new study by Polaris Market Research. 🌍 Market Overview Respiratory care devices are used in the diagnosis, treatment, and monitoring of patients with respiratory conditions. These devices play a critical role in managing both acute and chronic respiratory diseases, offering solutions such as oxygen concentrators, nebulizers, inhalers, CPAP devices, and ventilator devices. With the advent of non-invasive and smart connected equipment, patient care is becoming more efficient, personalized, and accessible. The COVID-19 pandemic served as a catalyst for the global respiratory devices market, dramatically increasing the demand for mechanical ventilators and oxygen therapy equipment. Although the pandemic has waned, awareness of respiratory health has surged, fostering sustained demand for pulmonary therapy equipment across hospitals, clinics, and home care settings. 🚀 Key Market Growth Drivers Surging Prevalence of Chronic Respiratory Diseases The increasing global burden of chronic respiratory diseases, particularly asthma and COPD, is a major factor driving market growth. According to the World Health Organization, over 300 million people suffer from asthma, and COPD is projected to become the third leading cause of death globally. Aging Global Population The global population aged 65 and above is growing rapidly. Older adults are more susceptible to respiratory conditions, necessitating the use of advanced monitoring and therapeutic devices. This demographic trend is expected to significantly boost market demand, particularly in developed economies. Technological Advancements and Smart Devices Integration of AI, IoT, and wireless technologies in respiratory care is revolutionizing the market. Devices now offer real-time monitoring, remote diagnostics, and enhanced patient compliance, making home respiratory monitoring increasingly feasible and effective. Post-COVID Healthcare Infrastructure Development The global healthcare system has witnessed heavy investments in critical care infrastructure post-COVID-19. Countries have bolstered their inventories of ventilator devices and oxygen supplies, creating a permanent demand baseline for emergency preparedness. Shift Toward Home-Based Care Patient preference for home care, cost-efficiency, and insurance support are encouraging the adoption of compact, portable respiratory solutions. Devices like portable oxygen concentrators and wearable respiratory monitors are seeing rising popularity. ⚠️ Market Challenges Despite strong growth potential, the respiratory care devices market faces several challenges: High Cost of Equipment: Advanced respiratory equipment, especially smart and portable devices, come at a high price, limiting accessibility in low-income regions. Reimbursement and Regulatory Hurdles: Inconsistent reimbursement policies across different countries and stringent regulatory requirements can hinder market expansion, particularly for new entrants. Device Maintenance and Calibration Issues: Regular maintenance, calibration, and user training are required for optimal functionality of respiratory devices, which may be challenging in remote or underserved areas. Lack of Skilled Healthcare Personnel: In many emerging markets, the shortage of trained professionals to operate complex devices like ventilators poses a major barrier. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market 🌐 Regional Market Analysis North America North America remains the largest market for respiratory care devices, owing to its robust healthcare infrastructure, high awareness, and favorable reimbursement policies. The U.S. has witnessed significant growth in home respiratory monitoring due to its aging population and the rise of telehealth services. Europe Europe holds a substantial share, supported by high incidence rates of respiratory disorders, government healthcare funding, and technological adoption. Germany, the UK, and France lead the European market. Asia-Pacific The Asia-Pacific region is projected to experience the highest growth rate, driven by rising pollution levels, increasing smoking rates, and expanding healthcare access. Countries like China and India are investing heavily in healthcare modernization and local manufacturing of pulmonary therapy equipment. Latin America and Middle East & Africa These regions are gradually developing their healthcare systems. Brazil, South Africa, and Saudi Arabia are showing increasing demand for ventilator devices and diagnostic tools due to growing awareness and government initiatives. 🏢 Key Companies in the Respiratory Care Devices Market Several global and regional players dominate the respiratory care devices market. Key companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their positions. Philips Respironics (Koninklijke Philips N.V.) A major player in sleep and respiratory care, known for its CPAP machines, oxygen concentrators, and home respiratory monitoring solutions. ResMed Inc. Specializes in cloud-connected devices for sleep apnea and other chronic respiratory diseases. Its cloud-based platform helps patients and providers track and manage respiratory health remotely. Medtronic plc Offers a wide range of respiratory support products including mechanical ventilators and monitoring systems. Strong presence in hospitals and critical care settings. Fisher & Paykel Healthcare Known for innovative respiratory humidification and ventilation products, especially in neonatal and adult intensive care. Drägerwerk AG & Co. KGaA A German company with a strong foothold in critical care, especially mechanical ventilators and anesthesia workstations. GE Healthcare Provides advanced respiratory diagnostic imaging and ventilator support technologies. Collaborating with AI firms to enhance device intelligence. Vyaire Medical Inc. A specialist in respiratory diagnostics and ventilation solutions, especially popular among clinics and home care providers. 🔮 Future Outlook The future of the respiratory care devices market looks promising with the continued focus on non-invasive, intelligent, and personalized care. The rise of pulmonary therapy equipment that integrates wearable technology, remote access, and data analytics will significantly transform the way respiratory conditions are managed globally. Investments in R&D, coupled with strong collaborations between med-tech firms and healthcare providers, are expected to yield groundbreaking innovations in the coming years. Meanwhile, the adoption of green technologies and sustainability practices in device manufacturing is gaining traction to address environmental concerns. 📌 Conclusion In conclusion, the global respiratory care devices market is entering a transformative phase, fueled by medical necessity, technological innovation, and changing healthcare delivery models. With robust growth across both developed and emerging markets, the sector offers ample opportunities for investors, manufacturers, and healthcare providers alike. As chronic respiratory illnesses continue to burden health systems worldwide, the emphasis on early diagnosis, personalized therapy, and accessible care will remain at the heart of respiratory device development. More Trending Latest Reports By Polaris Market Research: Voluntary Carbon Credit Market Precision Swine Farming Market D-Dimer Testing Market Flame Retardants Market Wax Melts Market Europe Facial Injectables Market Reverse Osmosis (RO) Membrane Market Electrolytic Manganese Dioxide Market Cyber Security Market

Knowing AMC Theatres ticket refund policy will help you handle any changes easily. AMC allows refunds and exchanges within a certain timeframe, depending on how you purchased your ticket. Knowing the policy in advance can save you time and hassle. #amctheatresticketrefundpolicy #howlongdoesamcrefundtake #canyougetarefundonamctickets #howtorefundmovieticketsamc #canyoucancelmovieticketsamc #howtocancelamctheatrestickets https://www.ticketexchangeinfo.com/amc-theatres-ticket-refund-policy/

Negli USA @SecKennedy finalmente apre uno squarcio di verità nella nauseante cortina di omertà e disinformazione che continua ad essere diffusa sul vaccino Covid. "Il Presidente Trump non crede che tutti debbano essere obbligati a vaccinarsi. C'è un intervento medico, presenta dei rischi, le persone dovrebbero poter scegliere per sé stesse. Riguardo al vaccino Covid, la raccomandazione per i bambini è sempre stata in dubbio. Ed era in dubbi perché i bambini avevano un rischio quasi nullo per il Covid-19. Alcuni bambini che hanno molto profonde morbidities possono presentare un leggero rischio, ma la maggiore parte dei bambini, no. Allora perché lo stiamo dando a decine di milioni di bambini quando il vaccino stesso ha rischi profondi? Abbiamo riscontrato enormi rischi associati a miocarditi, periocarditi con ictus, con altre lesioni, con lesioni neurologiche. E questo era chiaro fin dalla pratica clinica dai dati provenienti da Pfizer. In realtà ci sono stati più decessi, abbiamo avuto circa il 23% di morti in più nel gruppo vaccinato rispetto al gruppo placebo. Quindi dobbiamo fare delle domande e dobbiamo consultarci con i genitori. Dobbiamo dare alle persone il consenso informato. E non dovremmo dare raccomandazioni che fanno del male alla popolazione" #IoNonDimentico In the US @SecKennedy finally opens a glimpse of truth in the nauseating curtain of silence and misinformation that continues to be spread about the Covid vaccine. "President Trump does not believe that everyone should be forced to get vaccinated. There is a medical intervention, it has risks, people should be able to choose for themselves. With the Covid vaccine, the recommendation for children has always been in doubt. And it was in doubt because children had almost no risk for Covid-19. Some children who have very profound morbidities may have a slight risk, but most children, no. So why are we giving it to tens of millions of children when the vaccine itself has profound risks? We have seen enormous risks associated with myocarditis, periocarditis with stroke, with other injuries, with neurological injuries. And that was clear from the clinical practice from the data coming from Pfizer. There were actually more deaths, we had about 23% more deaths in the vaccinated group than in the placebo group. So we have to ask questions and we have to consult with parents. We have to give people informed consent. And we shouldn't give recommendations that harm the population" #IoNonDimentico Source: https://x.com/heather_parisi/status/1915004246937964992?t=qnMnzjQ6RWoijw6jYB9i8A&s=19

Fans can expect an exciting rock concert featuring their classic hits and new songs from their latest album, “Loom”. If you are excited about the Imagine Dragons tour, this blog will give you a hint on almost everything, including the tour dates, ticket details, possible setlists, and special surprises. #imaginedragonstour #imaginedragonstour2025 #imaginedragonstickets #imaginedragonsrockconcert #whoopenedforimaginedragonsdallas2025 https://www.ticketexchangeinfo.com/imagine-dragons-tour-dates-tickets-and-must-know-stuffs/